Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John R Wingard

Showing results (21-30 of 267) with videos related to

Pageof 27
Sort By:
Current Infectious Disease Reports|October 24, 2008
Combination antifungal therapy: from bench to bedsideBaldeep Wirk, John R Wingard
Current Infectious Disease Reports|September 28, 2011
Assessing responses to treatment of opportunistic mycoses and salvage strategiesBaldeep Wirk, John R Wingard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2005
Study of renal safety in amphotericin B lipid complex-treated patientsBarbara D Alexander, John R Wingard
Expert Review of Hematology|December 11, 2012
Diagnostic methods for invasive fungal diseases in patients with hematologic malignanciesMary Mansour Riwes, John R Wingard
Blood Reviews|June 20, 2006
New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignanciesHelen L Leather, John R Wingard
Current Opinion in Infectious Diseases|June 29, 2006
Is combination antifungal therapy for invasive aspergillosis a necessity in hematopoietic stem-cell transplant recipients?Helen L Leather, John R Wingard
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Thriving after hematopoietic stem cell transplant: a focus on positive changes in quality of lifeMichelle M Bishop, John R Wingard
Cancer Treatment and Research|April 8, 2014
Advances in the management of viral infectionsJack W Hsu, John R Wingard
Current Opinion in Infectious Diseases|July 20, 2002
Prophylaxis, empirical therapy, or pre-emptive therapy of fungal infections in immunocompromised patients: which is better for whom?Helen L Leather, John R Wingard
Current Opinion in Hematology|November 15, 2011
Use of antibacterial prophylaxis in patients with chemotherapy-induced neutropeniaJohn R Wingard, Lamis Eldjerou, Helen Leather
Pageof 27

Showing results (21-30 of 267) with videos related to

Sort By:
Pageof 27
Current Infectious Disease Reports|October 24, 2008
Combination antifungal therapy: from bench to bedsideBaldeep Wirk, John R Wingard
Current Infectious Disease Reports|September 28, 2011
Assessing responses to treatment of opportunistic mycoses and salvage strategiesBaldeep Wirk, John R Wingard
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 6, 2005
Study of renal safety in amphotericin B lipid complex-treated patientsBarbara D Alexander, John R Wingard
Expert Review of Hematology|December 11, 2012
Diagnostic methods for invasive fungal diseases in patients with hematologic malignanciesMary Mansour Riwes, John R Wingard
Blood Reviews|June 20, 2006
New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignanciesHelen L Leather, John R Wingard
Current Opinion in Infectious Diseases|June 29, 2006
Is combination antifungal therapy for invasive aspergillosis a necessity in hematopoietic stem-cell transplant recipients?Helen L Leather, John R Wingard
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Thriving after hematopoietic stem cell transplant: a focus on positive changes in quality of lifeMichelle M Bishop, John R Wingard
Cancer Treatment and Research|April 8, 2014
Advances in the management of viral infectionsJack W Hsu, John R Wingard
Current Opinion in Infectious Diseases|July 20, 2002
Prophylaxis, empirical therapy, or pre-emptive therapy of fungal infections in immunocompromised patients: which is better for whom?Helen L Leather, John R Wingard
Current Opinion in Hematology|November 15, 2011
Use of antibacterial prophylaxis in patients with chemotherapy-induced neutropeniaJohn R Wingard, Lamis Eldjerou, Helen Leather
Pageof 27